Otsuka Holdings

Otsuka Holdings es una de las ...

• Forbes Global 2000 (#770);
• Nikkei 225;
• Topix.

Otsuka Holdings es una empresa que cotiza bajo el símbolo de cotización 4578 (JP).

Otsuka Holdings tiene presencia directa en 10 países.

Otsuka Holdings posee 25 subsidiarias incluyendo Astex, Astex Pharmaceuticals y Cambridge Isotope Laboratories.

Ellos se encuentran en:

• Farmacia54%
• Equipos médicos27%
• Otro19%

Ver el organigrama con sus 240 ejecutivos principales

Biografías más buscadas en Otsuka Holdings

• Tatsuo Higuchi, President, Chief Executive Officer, Chairman of Th...
• Ko Sekiguchi, Independent Director
• Yukio Matsutani, Independent Director

Crear su alerta
para seguir los movimientos de los ejecutivos en Otsuka Holdings.

Otsuka Holdings tiene 1.816 competidores entre los que se incluyen Siemens Healthineers (Alemania), IQVIA (Estados Unidos) y Saint Francis Health System (Estados Unidos).

Popular M&A news in Salud

• Two Chairs acaba de anunciar una recaudación de fondos de 72 millones de dólares. (publicado el 18 de abril de 2024).
• Grow Therapy acaba de anunciar una recaudación de fondos de 88 millones de dólares. (publicado el 12 de abril de 2024).
• SSI Strategy and NDA Group have announced they will merge  (publicado el 8 de abril de 2024)..

Otros contactos sugeridos en el sector Salud

• Ari Bousbib - Chairman and Chief Executive Officer en IQVIA
• Ralph De La Torre - Chairman and Chief Executive Officer en Steward Health Care
• Paulo Junqueira Moll - Chief Executive Officer en Rede D'Or Sao Luiz

Saber más sobre el sector Salud >

Últimos comunicados de prensa de Otsuka Holdings

• Submission of an Application for the First Hematological Malignancies Gene Panel Test in Japan｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• FACEDUO Emotion Recognition Training VR now available - Support for those with developmental conditions such as autism spectrum disorder (ASD), which makes it difficult to read emotions -｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Works with Verily to Launch Longitudinal Mental Health Registry to Advance Novel Research in Psychiatry in the U.S.｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka and Lundbeck submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• U.S. Food and Drug Administration (FDA) Clearance of Rejoyn® First Prescription Digital Therapeutic Authorized in the U.S. for the Adjunctive Treatment of Major Depressive Disorder (MDD) symptoms｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka and Sumitomo Revise License Agreement - Otsuka holds exclusive rights to develop, manufacture, and commercialize ulotaront and SEP-380135 worldwide - ｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• New SOYJOY Fig & Raisin A Whole-Soy Nutrition Bar Enhanced with Flavorful Figs｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Launch of AR-Based Nutrition Education Game App, "Mogumogu Town"Collect "Mogumin" Food Characters and Build Your Town｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Sponsors TOKYO MARATHON 2024 POCARI SWEAT Supports Runners Achieve Their Goals｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Enters into Investment Contract with AN Venture Partners｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• View more press releases Close

Redes sociales sobre Otsuka Holdings

• Otsuka Holdings en Wikipedia, Google News y Yahoo Finance
• Otsuka Holdings en LinkedIn, Twitter y YouTube

Contactar a través de e-mail con sus ejecutivos Tatsuo Higuchi

Llame a Otsuka Holdings al +81 36...

Ver el organigrama

Register to receive your alert

Señalar un error